EGFR and hepatocellular carcinoma: As predicted by network pharmacology approach, ZJP may exert therapeutic effects on HCC primarily by regulating HCC cell proliferation and cell survival via PI3K-NF-κB, EGFR-MAPK, and CCND1 signaling pathways.